Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Arcutis Biotherapeutics Inc (ARQT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Arcutis's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
10.25 +0.15    +1.49%
- Closed. Currency in USD ( Disclaimer )
After Hours
10.15
-0.10
-0.98%
- Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,084,199
  • Bid/Ask: 10.07 / 10.34
  • Day's Range: 9.97 - 10.34
Arcutis 10.25 +0.15 +1.49%

ARQT Recent Sentiments

 
This page contains information on users’ sentiments for the Arcutis Biotherapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 17, 2024 Alberto JB   10.16 +0.89%
Apr 15, 2024 smith george   10.23 Apr 15, 2024 @ 10.36 +1.27%
Apr 12, 2024 jos van den Heuvel   10.90 Apr 15, 2024 @ 10.36 -4.95%
Apr 10, 2024 Manuel Artiñano...   12.44 -17.60%
Apr 08, 2024 Serdar Memmedov   11.74 -12.69%
Apr 05, 2024 Алексей Пан   11.57 Apr 08, 2024 @ 12.12 +4.75%
Apr 05, 2024 Patryk Rokicki   11.38 -9.93%
Apr 02, 2024 Federico KN   9.31 +10.10%
Mar 25, 2024 Bagda KZ   9.29 Apr 01, 2024 @ 9.43 +1.51%
Mar 21, 2024 asel serikbaeva   10.97 Apr 12, 2024 @ 10.20 -7.02%
Mar 18, 2024 Alberto JB   9.61 Apr 12, 2024 @ 10.20 +6.14%
Mar 11, 2024 Serdar Memmedov   9.88 Apr 05, 2024 @ 11.34 -14.78%
Mar 04, 2024 Eddy Nijs   11.00 Mar 11, 2024 @ 10.11 -8.09%
Feb 27, 2024 Federico KN   10.69 Mar 22, 2024 @ 9.61 -10.10%
Feb 27, 2024 AACan   11.05 Mar 04, 2024 @ 11.16 +1.00%
Feb 23, 2024 BLACK Kim   9.38 Mar 15, 2024 @ 10.66 +13.65%
Feb 23, 2024 Alberto JB   9.81 Mar 15, 2024 @ 10.66 +8.66%
Feb 22, 2024 Rich Liebert   9.57 Mar 15, 2024 @ 10.66 +11.39%
Feb 22, 2024 Liviu Raducu   9.55 Mar 15, 2024 @ 10.66 +11.62%
Feb 20, 2024 Aлексей Смоленцев   9.43 Mar 15, 2024 @ 10.66 +13.04%
Feb 16, 2024 Flavio Tangara   8.90 Feb 19, 2024 @ 9.30 +4.49%
Feb 14, 2024 Eddy Nijs   7.15 Feb 19, 2024 @ 9.30 +30.07%
Feb 12, 2024 Serdar Memmedov   6.49 Mar 08, 2024 @ 11.15 -71.80%
Feb 05, 2024 Nihat Kuzgun   5.93 Feb 26, 2024 @ 9.59 +61.72%
Feb 05, 2024 NİHAT KUZGUN   6.11 Feb 12, 2024 @ 6.43 +5.24%
Feb 05, 2024 NİHAT KUZGUN   6.11 Feb 12, 2024 @ 6.43 +5.24%
Feb 02, 2024 Dave C   6.59 Feb 05, 2024 @ 6.03 -8.50%
Jan 29, 2024 Donn Alegado   5.79 Feb 23, 2024 @ 9.68 +67.18%
Jan 29, 2024 Antonio Marín   5.80 Feb 23, 2024 @ 9.68 +66.90%
Jan 26, 2024 elias papastogiannidi   5.07 Feb 16, 2024 @ 9.30 +83.43%
Jan 23, 2024 Andrea Rilli   4.07 Jan 29, 2024 @ 5.39 +32.43%
Jan 23, 2024 Serdar Memmedov   4.07 Feb 09, 2024 @ 6.67 +63.88%
Jan 19, 2024 Alberto JB   3.26 Feb 09, 2024 @ 6.57 +101.53%
Jan 18, 2024 אשר לנקרי   3.16 Feb 09, 2024 @ 6.57 +107.91%
Jan 16, 2024 Rich Liebert   3.44 Feb 09, 2024 @ 6.57 +90.99%
Jan 11, 2024 Alejandro Poquet...   3.73 Feb 02, 2024 @ 6.07 +62.73%
Jan 11, 2024 Milat Örken   3.85 Feb 02, 2024 @ 6.07 -57.66%
Jan 09, 2024 라미 김   4.10 Feb 02, 2024 @ 6.07 +48.05%
Jan 09, 2024 Daniele Cinà   4.28 Feb 02, 2024 @ 6.07 +41.82%
Jan 05, 2024 יובל שעים   3.69 Jan 26, 2024 @ 5.30 +43.63%
Jan 04, 2024 يوسف العبيدي   4.12 Jan 26, 2024 @ 4.91 -19.17%
Jan 03, 2024 RAMA KRISHNA...   3.68 Jan 26, 2024 @ 5.30 +44.02%
Jan 03, 2024 andreas constantinide   3.56 Jan 26, 2024 @ 5.30 +48.88%
Jan 03, 2024 www tw   3.60 Jan 08, 2024 @ 3.70 +2.78%
Dec 29, 2023 Diego Facchi   3.32 Dec 29, 2023 @ 3.32 0.00%
Dec 28, 2023 بكر المريسي   3.41 Jan 19, 2024 @ 3.25 +4.69%
Dec 26, 2023 Elisabeth Arizmendi...   3.14 Jan 19, 2024 @ 3.25 +3.50%
Dec 22, 2023 Krzysztof Dekanski   2.94 Jan 12, 2024 @ 3.64 +23.81%
Dec 19, 2023 Nick Williams   2.52 Dec 25, 2023 @ 2.96 +17.46%
Dec 18, 2023 BLACK Kim   2.72 Dec 25, 2023 @ 2.96 +8.82%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ARQT Comments

Write your thoughts about Arcutis Biotherapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
joshua robinson
joshua robinson Mar 01, 2024 6:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anyone here winning too
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email